Apoptosis assay, or programmed cell death, is a growth limiting mechanism which is devised in case of extracellular signals because of DNA damage. In apoptosis assay, cells are genetically ablated. Apoptosis assays include cell shrinkage, chromosome condensation, membrane blebbing, DNA laddering, nuclear fragmentation, and others. Market Research Future (MRFR) has published an in-depth report on the global apoptosis assay market and has predicted a CAGR of 9.4% over the forecast period of 2018-2023. The market stood at USD 2.99Bn in 2017.

Get Free Sample Copy @https://www.marketresearchfuture.com/sample_request/6799

Aggressive efforts in cell-based research studies is a key factor driving the apoptosis assay market. The governments of multiple countries, as well as, various private entities are outlaying massive amounts on cell-based research studies. For instance, in 2017, the National Institutes of Health (NIH) invested USD 1.65 Bn for stem cell research. Such investments have been pouring in recently, given the surge in the incidence rate of chronic diseases across the globe. Autoimmune diseases, neurodegenerative diseases, and oncological disorders are spreading at an alarming rate. Such towering occurrences of such disorders have evoked intensive R&D activities for drug development, which is fueling the growth of the apoptosis assay market. In contrast, the apoptosis assays require hefty investments, which can trim the growth of the market over the forecast period.

Segmentation
The apoptosis assays market has been segmented based on product, detection technology, application, and end user.
By product, the apoptosis assays market has been segmented into kits, reagents, instruments, and others. The kits segment dominated the market in 2017.
By detection technology, the apoptosis assays market has been segmented into flow cytometry, fluorescence microscopy, western blot assessment, gel electrophoresis, and others. The flow cytometry segment led the market in 2017.
By application, the apoptosis assays market has been segmented into drug discovery and development, stem cell research, and others. Application-wise, the drug discovery and development segment is leading the market while the stem cell research segment is expected to be the fastest growing segment over the forecast period.

By end user, the apoptosis assays market has been segmented into pharmaceutical and biological companies, research institutes, and others. The pharmaceutical and biological companies segment is leading the market while the research institute segment is likely to be the fastest growing segment over the forecast period.

Regional Analysis
Region-wise, the apoptosis assay market has been segmented into the Americas, the Middle East & Africa (MEA), Europe, and Asia Pacific (APAC).

The Americas is dominating the global apoptosis assay market on account of the concentration of major market players in the region and increasing R&D expenditure. The prevalence of various chronic diseases is also considerably high in the region which has led to extensive R&D efforts. The US is a key contributor to the Americas market.

Europe accounts for the second largest share of the global apoptosis asay market. The growth of the market can be attributed to the expanding pharmaceutical and biotech industry in the region. In addition, government support has facilitated rigorous R&D activities in the field of cell-based research, which is boosting the growth of the market. Other factors supporting the growth of the market include heightened investment in R&D by market players, the presence of a well=established market players, and increasing awareness regarding targeted therapy.

The APAC apoptosis assay market is likely to exhibit the highest CAGR over the forecast period. Increasing R&D expenditure, surging prevalence of chronic diseases, and rising government support is driving the market in APAC.

Competitive Landscape
GeneCopoeia, Inc. (US), Danaher Corporation (US), GE Healthcare (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Geno Technology (US), Thermo Fisher Scientific (US), Promega Corporation (US) , Abcom plc, Merck KGaA (Germany), and Sartorius AG (Germany) are the key players in the apoptosis assays market.
Read Complete Report @https://www.marketresearchfuture.com/reports/apoptosis-assays-market-6799
NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: [email protected]